A 21 week study of Pregabalin (Lyrica®) for Patients with Inadequately Treated Painful Diabetic Peripheral Neuropathy.

Major Inclusion/Exclusion:

• Ages 18 or older
• Must have had Painful Diabetic Neuropathy for at least 3 months.
• Must currently be taking medication for pain other than Opioids that is inadequately controlling their pain.
• Must not be currently taking pregabalin (Lyrica®).

Alpine Clinical Research Center
1000 Alpine Avenue, Suite 200
Boulder, CO 80304
Phone: 303-443-7229
Email: info@alpineresearch.com